Aytu BioPharma (NASDAQ:AYTU) Issues Earnings Results

Aytu BioPharma (NASDAQ:AYTU) announced its quarterly earnings results on Wednesday. The company reported ($0.28) earnings per share (EPS) for the quarter, Zacks reports. Aytu BioPharma had a negative net margin of 8.28% and a negative return on equity of 21.89%.

Aytu BioPharma Stock Down 2.1 %

Shares of NASDAQ:AYTU traded down $0.03 during trading on Wednesday, hitting $1.39. 57,227 shares of the company were exchanged, compared to its average volume of 24,390. The firm has a fifty day moving average price of $1.62 and a two-hundred day moving average price of $2.01. The stock has a market cap of $8.55 million, a price-to-earnings ratio of -1.13 and a beta of -1.45. The company has a current ratio of 0.99, a quick ratio of 0.80 and a debt-to-equity ratio of 0.35. Aytu BioPharma has a fifty-two week low of $1.30 and a fifty-two week high of $3.45.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.